MRK vs PFE: six-factor score, head to head
How Merck & Co. and Pfizer Inc.compare on Tapeline’s published six-factor composite score. Descriptive only — a rules-based reading of each name, not a recommendation.
Today, MRK scores 84 and PFE scores 55on Tapeline’s six-factor composite. MRK carries the higher composite score today. Here’s how the six factors line up.
| Factor | MRK | PFE |
|---|---|---|
| Trend | 97 | 88 |
| Relative Strength | 74 | 37 |
| Fundamentals | 87 | 59 |
| Smart Money | 90 | 17 |
| Macro | 75 | 75 |
| Momentum | 75 | 30 |
MRK · Health Care
smart-money factor in the lower band of its range, with relative-strength factor above the midpoint vs healthcare peers.
PFE · Health Care
fundamentals factor on the upper side of its range.
The Tapeline Score is a descriptive, rules-based measure for information only — not investment advice or a recommendation to buy or sell. See the six-factor method and the public scorecard.
More comparisons
FAQ
- How do MRK and PFE compare on Tapeline?
- Tapeline scores MRK 84/100 and PFE 55/100 on its published six-factor composite (trend, relative strength, fundamentals, smart money, macro, momentum). The page breaks the two scores down factor by factor.
- Which has the higher Tapeline score, MRK or PFE?
- MRK has the higher composite score today (84 vs 55). The score is a descriptive measure, not a recommendation — see the per-factor breakdown above.
- Is this investment advice?
- No. Tapeline publishes a descriptive, rules-based six-factor score for information only. It is not a recommendation to buy or sell, and every top pick is back-checked publicly at /scorecard.